IMPACT OF DIFFERENT INDUCTION REGIMENS ON THE OUTCOME OF PRIMARY MEDIASTINAL B CELL LYMPHOMA IN THE PROSPECTIVE IELSG 37 TRIAL. (17th June 2021)

• Record Type: Journal Article
• Authors: Martelli, M.; Zucca, E.; Botto, B.; Kryachok, I.; Ceriani, L.; Balzarotti, M.; Tucci, A.; Cabras, M. G.; Zilioli, V. R.; Rusconi, C.; Angrilli, F.; Arcaini, L.; Iwanicka, A. Dabrowska; Ferreri, Andrés J.M.; Merli, F.; Zhao, W.; Hodgson, D.; Ionescu, C.; Fosså, A.; Cwynarski, K.; Mikhaeel, G.; Jerkeman, M.; Janikova, A.; Hüttmann, A.; Ciccone, G.; Metser, U.; Barrington, S.; Malkowski, B.; Versari, A.; Esposito, F.; Cozens, K.; Ielmini, N.; Ricardi, R.; Cavalli, F.; Johnson, P.; Davies, A.;
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Chemotherapy Combination Therapies Immunotherapy; Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.49_2879
• Languages: English
• ISSNs: 0278-0232